Garry M. Dolton

This paper uses intradermal GAD-Alum challenge and scRNA-seq to identify and profile GAD-reactive T cells in type 1 diabetes.

This study shows that the probiotic CBM588 enhances antitumor γδ T-cell responses in lung cancer patients undergoing checkpoint blockade therapy.